Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

E1900000

17α-Ethynylestradiol

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

Ethinylestradiol

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C20H24O2
Numéro CAS:
57-63-6
Poids moléculaire :
296.40
Numéro Beilstein :
2419975
Numéro MDL:
MFCD00003690
Code UNSPSC :
41116107
ID de substance PubChem :
329799022
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

ethinyl estradiol

Fabricant/nom de marque

EDQM

Technique(s)

HPLC: suitable
gas chromatography (GC): suitable

Pf

182-183 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Chaîne SMILES 

[H][C@]12CC[C@@]3(C)[C@@]([H])(CC[C@@]3(O)C#C)[C@]1([H])CCc4cc(O)ccc24

InChI

1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1

Clé InChI

BFPYWIDHMRZLRN-SLHNCBLASA-N

Informations sur le gène

human ... ESR1(2099)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ethinylestradiol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Pictogrammes

Health hazardExclamation markEnvironment
GHS08,GHS07,GHS09

Mention d'avertissement

Danger

Mentions de danger

H302,H351,H360Fd,H410

Classification des risques

Acute Tox. 4 Oral - Aquatic Chronic 1 - Carc. 2 - Repr. 1A

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 9

1 of 9

vibrant-m

Y0001379

Levonorgestrel impurity B

Cyproterone acetate European Pharmacopoeia (EP) Reference Standard

C3283000

Cyproterone acetate

Cyproterone acetate British Pharmacopoeia (BP) Reference Standard

BP688

Cyproterone acetate

Drospirenone European Pharmacopoeia (EP) Reference Standard

Y0001105

Drospirenone

Desogestrel European Pharmacopoeia (EP) Reference Standard

Y0000509

Desogestrel

Levonorgestrel Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1850

Levonorgestrel

Dienogest European Pharmacopoeia (EP) Reference Standard

Y0001785

Dienogest

Levonorgestrel United States Pharmacopeia (USP) Reference Standard

USP

1362602

Levonorgestrel

Drospirenone ≥98% (HPLC)

Sigma-Aldrich

SML0147

Drospirenone

Jürgen Dinger et al.
Obstetrics and gynecology, 122(4), 800-808 (2013-10-03)
To compare the risks of short-term and long-term use of an etonogestrel-containing and ethinylestradiol-containing vaginal ring and combined oral contraceptive pills (OCPs) in a routine clinical study population. This was a prospective, controlled, noninterventional cohort study performed in the United
C Piérard-Franchimont et al.
Maturitas, 22(2), 151-154 (1995-09-01)
The effects of menopause and hormone replacement therapy (HRT) on the epidermis are largely unknown. The aim of this study was to model and measure the influence of estrogen-transdermal HRT on subtle physiological changes taking place in the epidermis during
Konrad F Koehler et al.
Endocrine reviews, 26(3), 465-478 (2005-04-29)
We have known for many years that estrogen is more than the female hormone. It is essential in the male gonads, and in both sexes, estrogen has functions in the skeleton and central nervous system, on behavior, and in the
Jie Han et al.
Water research, 47(7), 2273-2284 (2013-03-08)
This study demonstrates that ethinylestradiol (EE2), a priority estrogenic contaminant in water, can be rapidly and selectively removed from aqueous solutions using industrial-grade polyamide 612 (PA612) particles as adsorbents. Isothermal studies showed that nonporous low surface area (20 m(2) g(-1)) PA612 particles
Kristina Gemzell-Danielsson et al.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 29 Suppl 1, 1-14 (2013-03-06)
There have been numerous attempts to control fertility after unprotected sexual intercourse (UPSI). From very bizarre methods like the vaginal application of Coca Cola to the more serious attempts using calcium antagonists influencing fertility parameters in sperm to hormonal methods
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique